Published in Lancet on February 08, 1986
Quantitative analysis reveals expansion of human hematopoietic repopulating cells after short-term ex vivo culture. J Exp Med (1997) 2.03
Prospects for cure in leukaemia. J Clin Pathol (1987) 1.07
Treatment of acute myeloid leukemia cells in vitro with a monoclonal antibody recognizing a myeloid differentiation antigen allows normal progenitor cells to be expressed. J Clin Invest (1987) 0.91
Long-term in vitro correction of alpha-L-iduronidase deficiency (Hurler syndrome) in human bone marrow. Proc Natl Acad Sci U S A (1996) 0.81
A C. elegans mutant that lives twice as long as wild type. Nature (1993) 20.42
Conditions controlling the proliferation of haemopoietic stem cells in vitro. J Cell Physiol (1977) 6.82
Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer. J Clin Oncol (1997) 5.89
Growth of factor-dependent hemopoietic precursor cell lines. J Exp Med (1980) 5.80
Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial. Lancet (1998) 5.35
Cyclosporin A to prevent graft-versus-host disease in man after allogeneic bone-marrow transplantation. Lancet (1980) 4.21
Systematic implementation of an advance directive program in nursing homes: a randomized controlled trial. JAMA (2000) 3.87
Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis. Nature (1990) 3.80
Growth of human umbilical-cord blood in longterm haemopoietic cultures. Lancet (1992) 3.54
Mutational inactivation of transforming growth factor beta receptor type II in microsatellite stable colon cancers. Cancer Res (1999) 3.40
Heparan sulphate bound growth factors: a mechanism for stromal cell mediated haemopoiesis. Nature (1988) 3.22
Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues: correlation with preinvasive and invasive phenotypes. Clin Cancer Res (2000) 3.03
Hypocholesterolemia is associated with immune dysfunction in early human immunodeficiency virus-1 infection. Am J Med (1993) 2.96
Accelerated telomere shortening in young recipients of allogeneic bone-marrow transplants. Lancet (1998) 2.87
Telomerase-independent lengthening of yeast telomeres occurs by an abrupt Rad50p-dependent, Rif-inhibited recombinational process. Mol Cell (2000) 2.76
The Finland-United States investigation of non-insulin-dependent diabetes mellitus genetics (FUSION) study. I. An autosomal genome scan for genes that predispose to type 2 diabetes. Am J Hum Genet (2000) 2.50
Growth factors in development, transformation, and tumorigenesis. Cell (1991) 2.49
Residential radon exposure and lung cancer among nonsmoking women. J Natl Cancer Inst (1994) 2.45
Replacement of potassium chloride by potassium glutamate dramatically enhances protein-DNA interactions in vitro. Biochemistry (1987) 2.45
Poverty, psychological disorder and disability in primary care attenders in Goa, India. Br J Psychiatry (1998) 2.25
De novo donor-specific antibody at the time of kidney transplant biopsy associates with microvascular pathology and late graft failure. Am J Transplant (2009) 2.24
Do stem cells play dice? Blood (1998) 2.19
A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer. Ann Oncol (1998) 2.18
Extramedullary plasmacytoma of the head and neck region: clinicopathological correlation in 25 cases. Br J Cancer (1997) 2.18
Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation (2001) 2.03
The place of bone-marrow transplantation in acute myelogenous leukaemia. Lancet (1980) 2.03
Parenteral acyclovir therapy for herpesvirus infections in man. Lancet (1979) 1.99
Local structural elements in the mostly unstructured transcriptional activation domain of human p53. J Biol Chem (2000) 1.98
Neo-adjuvant and adjuvant hormone therapy for localised and locally advanced prostate cancer. Cochrane Database Syst Rev (2006) 1.97
Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer. Br J Cancer (1987) 1.97
Targeted disruption of the ubiquitous CNC-bZIP transcription factor, Nrf-1, results in anemia and embryonic lethality in mice. EMBO J (1998) 1.97
The effect of oral and inhaled beclomethasone dipropionate on adrenal function. Clin Allergy (1973) 1.96
A new diagnostic algorithm for antibody-mediated microcirculation inflammation in kidney transplants. Am J Transplant (2012) 1.93
Differentiation and proliferation of hemopoietic cells in culture. Methods Cell Biol (1976) 1.92
Type 2 diabetes: evidence for linkage on chromosome 20 in 716 Finnish affected sib pairs. Proc Natl Acad Sci U S A (1999) 1.91
Kaposi's sarcoma-associated herpesvirus open reading frame 57 encodes a posttranscriptional regulator with multiple distinct activities. J Virol (2000) 1.89
Altering telomere structure allows telomerase to act in yeast lacking ATM kinases. Curr Biol (2001) 1.89
Self-renewal and differentiation of interleukin-3-dependent multipotent stem cells are modulated by stromal cells and serum factors. Differentiation (1986) 1.88
Markedly elevated levels of an endogenous sarc protein in a hemopoietic precursor cell line. Mol Cell Biol (1981) 1.83
Suppression of apoptosis allows differentiation and development of a multipotent hemopoietic cell line in the absence of added growth factors. Cell (1993) 1.82
Broken rotational symmetry in the pseudogap phase of a high-T(c) superconductor. Nature (2010) 1.82
Characterization and partial purification of a haemopoietic cell growth factor in WEHI-3 cell conditioned medium. Biochem J (1983) 1.82
Isolation and characterisation of a bipotential haematopoietic cell line. Nature (1979) 1.80
Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trial. Br J Cancer (1999) 1.80
Paediatric anaesthesia--who should do it? Anaesthesia (1998) 1.78
Perspectives of commissioners and cancer specialists in prioritising new cancer drugs: impact of the evidence threshold. BMJ (1999) 1.77
The relative spatial distributions of CFUs and CFUc in the normal mouse femur. Blood (1975) 1.77
Detection of N-Ras codon 61 mutations in subpopulations of tumor cells in multiple myeloma at presentation. Blood (2001) 1.75
Selection of axial growth sites in yeast requires Axl2p, a novel plasma membrane glycoprotein. Genes Dev (1996) 1.75
Nationwide survey of human parasite in China. Southeast Asian J Trop Med Public Health (1994) 1.72
The use of granulocyte colony-stimulating factor to increase the intensity of treatment with doxorubicin in patients with advanced breast and ovarian cancer. Br J Cancer (1989) 1.65
Evidence for airborne transmission of Norwalk-like virus (NLV) in a hotel restaurant. Epidemiol Infect (2000) 1.64
NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: evidence for NK cell involvement in antibody-mediated rejection. Am J Transplant (2010) 1.62
Metabolism of beclomethasone dipropionate by animals and man. Postgrad Med J (1975) 1.60
The nature of biopsies with "borderline rejection" and prospects for eliminating this category. Am J Transplant (2011) 1.60
Dimerization properties of human BAD. Identification of a BH-3 domain and analysis of its binding to mutant BCL-2 and BCL-XL proteins. J Biol Chem (1997) 1.58
Large deletions at the t(9;22) breakpoint are common and may identify a poor-prognosis subgroup of patients with chronic myeloid leukemia. Blood (2000) 1.58
Hospital policy on appropriate use of life-sustaining treatment. University of Toronto Joint Centre for Bioethics/Critical Care Medicine Program Task Force. Crit Care Med (2001) 1.57
Repression of the gene encoding the TGF-beta type II receptor is a major target of the EWS-FLI1 oncoprotein. Nat Genet (1999) 1.57
Transplantation potential of hematopoietic cells released into the circulation during routine chemotherapy for non-Hodgkin's lymphoma. Blood (1993) 1.56
Intraocular pressure alterations following intravitreal triamcinolone acetonide. Br J Ophthalmol (2006) 1.55
Intravenous therapy with high doses of ranitidine and omeprazole in critically ill patients with bleeding peptic ulcerations of the upper intestinal tract: an open randomized controlled trial. Digestion (1990) 1.54
The molecular phenotype of heart transplant biopsies: relationship to histopathological and clinical variables. Am J Transplant (2010) 1.54
The Finland-United States investigation of non-insulin-dependent diabetes mellitus genetics (FUSION) study. II. An autosomal genome scan for diabetes-related quantitative-trait loci. Am J Hum Genet (2000) 1.53
Effect of ventricular shock strength on cardiac hemodynamics. J Cardiovasc Electrophysiol (1998) 1.53
Stromal cell associated haemopoiesis. J Cell Physiol Suppl (1982) 1.52
Local relapse in primary breast cancer patients with unexcised positive surgical margins after lumpectomy, radiotherapy and chemoendocrine therapy. Ann Oncol (1999) 1.51
Performing bone marrow biopsies with or without sedation: a comparison. Clin Lab Haematol (2004) 1.50
HLA class II alleles and susceptibility and resistance to insulin dependent diabetes mellitus in Mexican-American families. Nat Genet (1993) 1.50
Altered development and cytokine responses of myeloid progenitors in the absence of transcription factor, interferon consensus sequence binding protein. Blood (1999) 1.49
The molecular landscape of antibody-mediated kidney transplant rejection: evidence for NK involvement through CD16a Fc receptors. Am J Transplant (2015) 1.48
In vitro assessment of marrow 'stem cell' and stromal cell function in aplastic anaemia. Br J Haematol (1991) 1.48
Biodegradable rapamycin-eluting nano-fiber membrane-covered metal stent placement to reduce fibroblast proliferation in experimental stricture in a canine model. Endoscopy (2013) 1.48
Interleukin 1 activates phospholipase A2 in rabbit chondrocytes: a possible signal for IL 1 action. J Immunol (1986) 1.47
Ranitidine--a new H2-receptor antagonist. Gut (1980) 1.47
The effects of norethisterone on endometrial abnormalities identified by transvaginal ultrasound screening of healthy post-menopausal women on tamoxifen or placebo. Br J Cancer (1998) 1.44
Photodynamic therapy in the canine prostate using motexafin lutetium. Clin Cancer Res (2001) 1.43
The molecular phenotype of 6-week protocol biopsies from human renal allografts: reflections of prior injury but not future course. Am J Transplant (2010) 1.43
Right-to-left shunts as a cause of juxtacortical spots in patients with migraine. Eur J Neurol (2012) 1.42
Fractures of the humeral shaft: a retrospective study of 240 adult fractures. Clin Orthop Relat Res (1975) 1.42
Metabolic studies of Salbutanol-3H: a new bronchodilator, in rat, rabbit, dog and man. Eur J Pharmacol (1971) 1.41
The dribble speed for spinal anesthesia. Reg Anesth (1994) 1.41
X-ray diffraction observations of a charge-density-wave order in superconducting ortho-II YBa2Cu3O6.54 single crystals in zero magnetic field. Phys Rev Lett (2013) 1.41
A randomised study of the impact of different styles of patient information leaflets for randomised controlled trials on children's understanding. Arch Dis Child (2005) 1.40
CD34+AC133+ cells isolated from cord blood are highly enriched in long-term culture-initiating cells, NOD/SCID-repopulating cells and dendritic cell progenitors. Stem Cells (1998) 1.40
Combined innominate artery reconstruction and coronary artery bypass grafting. Zhonghua Yi Xue Za Zhi (Taipei) (2001) 1.39
Tumour lysis syndrome, case report and review of the literature. Ann Oncol (1996) 1.39
The human beta globin locus introduced by YAC transfer exhibits a specific and reproducible pattern of developmental regulation in transgenic mice. Blood (1997) 1.39
Veterinary prescription diets. Vet Rec (1991) 1.39
Hypospadias repair: collaboration between urologist and plastic surgeon. Ann Plast Surg (2000) 1.38